BioAtla, Inc. SEC filings BCAB

BioAtla, Inc. has 509 filings in SEC EDGAR's recent list, going back to Oct 6, 2020. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (material agreement, agreement ended, unregistered share sale). The company's fiscal year ends on December 31.

BioAtla, Inc. SEC filings
Form Description Filed Period
EFFECT Filing Oct 29, 2026 —
424B3 Prospectus Oct 29, 2026 —
RW Filing Oct 27, 2026 —
S-1 Registration statement Oct 20, 2026 —
8-K Current report
Material agreement, Agreement ended, Unregistered share sale
Oct 20, 2026 Oct 15, 2026
8-K Current report
Officer or director change
Sep 29, 2026 Sep 23, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
8-K Current report
Listing notice
Aug 28, 2026 Aug 26, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Jul 16, 2026 Jul 16, 2026
4 Insider transaction Jun 5, 2026 Mar 11, 2026
4 Insider transaction Jun 5, 2026 Mar 12, 2026
4 Insider transaction Jun 5, 2026 Mar 11, 2026
ARS Annual report to shareholders Jun 3, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 3, 2026 —
DEF 14A Proxy statement Jun 3, 2026 Jun 3, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-K/A Amended annual report Apr 29, 2026 Dec 31, 2025
8-K Current report
Other events
Apr 2, 2026 Apr 2, 2026
S-8 Employee stock plan registration Mar 31, 2026 —
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 31, 2026 Mar 31, 2026
8-K Current report
Officer or director change, Shareholder vote results
Mar 23, 2026 Mar 17, 2026
424B2 Prospectus Mar 20, 2026 —
424B2 Prospectus Mar 13, 2026 —
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 11, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
424B2 Prospectus Mar 9, 2026 —
4 Insider transaction Mar 2, 2026 Feb 28, 2026
4 Insider transaction Mar 2, 2026 Feb 28, 2026
4 Insider transaction Mar 2, 2026 Feb 28, 2026
4 Insider transaction Mar 2, 2026 Feb 28, 2026
DEFA14A Additional proxy material Mar 2, 2026 —
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
Mar 2, 2026 Feb 24, 2026
DEFM14A Filing Feb 11, 2026 —
8-K Current report
Other events
Feb 9, 2026 Feb 8, 2026
8-K Current report
Listing notice, Regulation FD disclosure
Feb 6, 2026 Feb 6, 2026
PREM14A Filing Jan 30, 2026 Jan 30, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
Jan 30, 2026 Jan 26, 2026
S-3 Shelf registration Jan 16, 2026 —
DEFA14A Additional proxy material Jan 15, 2026 —
8-K Current report
Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results, Other events
Jan 12, 2026 Jan 9, 2026
DEFA14A Additional proxy material Dec 31, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Dec 31, 2025 Dec 30, 2025
8-K Current report
Shareholder vote results, Other events
Dec 30, 2025 Dec 30, 2025
DEF 14A Proxy statement Dec 5, 2025 Dec 5, 2025
4 Insider transaction Dec 1, 2025 Nov 30, 2025
4 Insider transaction Dec 1, 2025 Nov 30, 2025
4 Insider transaction Dec 1, 2025 Nov 30, 2025
4 Insider transaction Dec 1, 2025 Nov 30, 2025
PRE 14A Preliminary proxy statement Nov 24, 2025 Nov 24, 2025
424B5 Prospectus supplement Nov 21, 2025 —
8-K Current report
Material agreement, New debt
Nov 21, 2025 Nov 20, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 15, 2025 —
8-K Current report
Other events
Sep 22, 2025 Sep 16, 2025
4 Insider transaction Sep 2, 2025 Aug 31, 2025
4 Insider transaction Sep 2, 2025 Aug 31, 2025
4 Insider transaction Sep 2, 2025 Aug 31, 2025
4 Insider transaction Sep 2, 2025 Aug 31, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 20, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 18, 2025
4 Insider transaction Jun 18, 2025 Jun 18, 2025
4 Insider transaction Jun 18, 2025 Jun 18, 2025
4 Insider transaction Jun 18, 2025 Jun 18, 2025
4 Insider transaction Jun 18, 2025 Jun 18, 2025
4 Insider transaction Jun 18, 2025 Jun 18, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 20, 2025 —
8-K Current report
Listing notice
May 16, 2025 May 12, 2025
424B3 Prospectus May 16, 2025 —
EFFECT Filing May 14, 2025 —
CORRESP Letter to the SEC May 12, 2025 —
UPLOAD Letter from the SEC May 9, 2025 —
S-3 Shelf registration May 6, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 25, 2025 —
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Apr 24, 2025
S-8 Employee stock plan registration Mar 28, 2025 —
10-K Annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Results of operations, Exit or restructuring costs
Mar 27, 2025 Mar 27, 2025
SCHEDULE 13G Ownership over 5% (passive) Mar 18, 2025 —
8-K Current report
Officer or director change
Mar 14, 2025 Mar 11, 2025
4 Insider transaction Mar 13, 2025 Mar 11, 2025
4 Insider transaction Mar 13, 2025 Mar 12, 2025
4 Insider transaction Mar 13, 2025 Mar 11, 2025
4 Insider transaction Mar 13, 2025 Mar 11, 2025
4 Insider transaction Feb 24, 2025 Feb 16, 2025
4 Insider transaction Feb 24, 2025 Feb 15, 2025
4 Insider transaction Feb 24, 2025 Feb 15, 2025
4 Insider transaction Feb 24, 2025 Feb 15, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
8-K Current report
Listing notice
Feb 7, 2025 Feb 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 24, 2025 —
424B5 Prospectus supplement Dec 20, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Dec 20, 2024 Dec 19, 2024
8-K Current report
Regulation FD disclosure
Dec 20, 2024 Dec 20, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13D/A Amended ownership over 5% (active) Oct 2, 2024 —
8-K Current report
Material agreement
Sep 23, 2024 Sep 23, 2024
SC 13D/A Amended ownership over 5% (active) Sep 6, 2024 —
4 Insider transaction Sep 3, 2024 Aug 31, 2024
4 Insider transaction Sep 3, 2024 Aug 31, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
SC 13G Ownership over 5% (passive) Aug 7, 2024 —
4 Insider transaction Aug 1, 2024 Jul 31, 2024
4 Insider transaction Aug 1, 2024 Jul 31, 2024
SC 13G/A Amended ownership over 5% (passive) Jul 8, 2024 —
4 Insider transaction Jul 1, 2024 Jun 30, 2024
4 Insider transaction Jul 1, 2024 Jun 30, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
8-K Current report
Shareholder vote results
Jun 13, 2024 Jun 13, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
8-K Current report
Other events
May 17, 2024 May 15, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
4 Insider transaction May 1, 2024 Apr 30, 2024
4 Insider transaction May 1, 2024 Apr 30, 2024
8-K Current report
Bylaw or fiscal year change
Apr 24, 2024 Apr 22, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 24, 2024 —
DEF 14A Proxy statement Apr 24, 2024 Jun 13, 2024
SC 13D/A Amended ownership over 5% (active) Apr 16, 2024 —
4 Insider transaction Apr 1, 2024 Mar 31, 2024
4 Insider transaction Apr 1, 2024 Mar 31, 2024
S-8 Employee stock plan registration Mar 26, 2024 —
10-K Annual report Mar 26, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 26, 2024 Mar 26, 2024
4 Insider transaction Mar 1, 2024 Feb 29, 2024
4 Insider transaction Mar 1, 2024 Feb 29, 2024
8-K Current report
Officer or director change
Feb 21, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 16, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
8-K Current report
Other events
Feb 12, 2024 Feb 6, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
4 Insider transaction Feb 1, 2024 Jan 31, 2024
4 Insider transaction Feb 1, 2024 Jan 31, 2024
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
4 Insider transaction Jan 19, 2024 Mar 28, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
8-K Current report
Bylaw or fiscal year change
Jan 8, 2024 Jan 5, 2024
4 Insider transaction Jan 3, 2024 Dec 31, 2023
4 Insider transaction Jan 3, 2024 Dec 31, 2023
4 Insider transaction Jan 3, 2024 Dec 31, 2023
4 Insider transaction Jan 3, 2024 Dec 31, 2023
4 Insider transaction Dec 26, 2023 Dec 26, 2023
4 Insider transaction Dec 20, 2023 Dec 20, 2023
4 Insider transaction Dec 19, 2023 Dec 19, 2023
4 Insider transaction Dec 19, 2023 Dec 19, 2023
8-K Current report
Regulation FD disclosure, Other events
Dec 13, 2023 Dec 13, 2023
8-K Current report
Other events
Dec 4, 2023 Dec 4, 2023
4 Insider transaction Dec 1, 2023 Nov 30, 2023
4 Insider transaction Dec 1, 2023 Nov 30, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
4 Insider transaction Nov 2, 2023 Oct 31, 2023
4 Insider transaction Nov 2, 2023 Oct 31, 2023
4 Insider transaction Nov 1, 2023 Oct 31, 2023
4 Insider transaction Nov 1, 2023 Oct 31, 2023
4 Insider transaction Nov 1, 2023 Oct 31, 2023
4 Insider transaction Oct 3, 2023 Sep 30, 2023
4 Insider transaction Oct 3, 2023 Sep 30, 2023
4 Insider transaction Oct 2, 2023 Sep 30, 2023
4 Insider transaction Oct 2, 2023 Sep 30, 2023
4 Insider transaction Oct 2, 2023 Sep 30, 2023
4 Insider transaction Oct 2, 2023 Sep 30, 2023
4 Insider transaction Oct 2, 2023 Sep 30, 2023
4 Insider transaction Sep 13, 2023 Sep 8, 2023
4 Insider transaction Sep 1, 2023 Aug 31, 2023
4 Insider transaction Sep 1, 2023 Aug 31, 2023
4 Insider transaction Sep 1, 2023 Aug 31, 2023
4 Insider transaction Sep 1, 2023 Aug 31, 2023
4 Insider transaction Sep 1, 2023 Aug 31, 2023
4 Insider transaction Aug 1, 2023 Jul 31, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
BCAB (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1826892

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.